Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Cash back taxes can be confusing. This guide provides essential insights to help you navigate your tax responsibilities.
22,480 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Klarna and Sezzle stand out in the evolving fintech scene, but they offer very different risk/reward profiles. This g...
As markets swing and inflation cools, cash-rich utility retirees count on reliable, regulated cash flows. This report...
Lemonade posted first positive GAAP free cash flow in the latest quarter, a milestone that reshapes the insurtech nar...
Geopolitics are shaking energy markets, but savvy investors can find steadiness. This piece explains how Iran roiling...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Volatility tests reshape the defensive playbook in consumer staples. Coca-Cola edges ahead of PepsiCo on cash flow an...
Concentra's Q4 2025 results shed light on its growth engine and profitability. This article breaks down the numbers, ...
Broadcom stands at a pivotal crossroads as AI spending shifts from pilots to production. This article lays out the ke...
This in-depth guide breaks down what to watch in Ziff Davis's Q1 2026 earnings transcript, how growth drivers shape t...
SpaceX is counting down to a defining moment within two weeks. This guide explains what the milestone could mean for ...
We unpack the Q4 results and what ftai (fip) 2025 earnings imply for the year ahead. Learn the key drivers, risk fact...